Longitude Capital is a leading healthcare venture capital firm that invests in transformative biotech, medical technology, and health solutions companies. The firm focuses on companies with therapies, devices, diagnostics, and services that significantly improve the lives of patients and provide solid returns for investors.

Longitude Capital specializes in making venture growth investments in biotechnology, medical technology and health solutions companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. Longitude Capital invests in both privately held and publicly traded life science companies through a variety of investment approaches. Media Contact:Maggie Jamisonmjamison@longitudecapital.com

Esperion

Jazz Pharmaceuticals

Collegium Pharmaceutical

RxSight

Kala Pharmaceuticals

Molecular Templates

Vaxcyte

Talaris Therapeutics

Tricida

Vera Therapeutics

Venus Concept

Inozyme

Poseida Therapeutics

Practice Fusion

Rapid Micro Biosystems

89bio

Aimmune Therapeutics

Amunix

Aptinyx

Eargo

Axonics Modulation Technologies

Longitude Capital

COM:LONGITUDECAPITAL

Longitude Capital

Analysis Not Available